000756.SZ लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 12:34):

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products...

Stats
आज की मात्रा	8.52M
औसत मात्रा	9.41M
बाजार मूल्य	8.87B
EPS	CNY0 ( 2024-04-19 )
अगली कमाई की तारीख	( CNY0 ) 2024-06-25
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	22.75
ATR14	CNY0.0120 (0.07%)

मात्रा सहसंबंध

लंबा: -0.03 (neutral)

छोटा: 0.45 (neutral)

Signal:(52.732) Neutral

Shandong Xinhua सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Shandong Xinhua सहसंबंध - मुद्रा/वस्त्र

0.07
( neutral )

-0.25
( neutral )

0.00
( neutral )

0.10
( neutral )

-0.12
( neutral )

0.48
( neutral )

Shandong Xinhua वित्तीय

Annual	2023
राजस्व:	CNY8.01B
सकल लाभ:	CNY2.21B (27.58 %)
EPS:	CNY0.740

FY	2023
राजस्व:	CNY8.01B
सकल लाभ:	CNY2.21B (27.58 %)
EPS:	CNY0.740

FY	2022
राजस्व:	CNY7.50B
सकल लाभ:	CNY2.04B (27.15 %)
EPS:	CNY0.620

FY	2021
राजस्व:	CNY6.56B
सकल लाभ:	CNY1.77B (27.04 %)
EPS:	CNY0.560

Financial Reports:

No articles found.

Shandong Xinhua

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand. It also provides prepared Chinese herbal medicine decoction, traditional Chinese medicines, chemical preparations, antibiotics, biochemical medicines, chemical bulk drugs, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc.; and chemical raw materials, such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. In addition, the company offers materials and intermediates, powders for injection and tablets; tablets, hard capsules, granules, and dry suspension; imports and exports goods and technologies; designs medical projects; and health products research and development activities. Further, it engages in the certification business; electrical equipment engineering; and installation and testing of chemical equipment and electrical equipment, as well as the sale of mechanical, hardware, and electrical equipment. Additionally, the company produces and sells high-end steroid system APIs and intermediates; and provides internet data, internet sells, and internet information services for pharmaceuticals and medical devices, etc. It operates in the People's Republic of China, the Americas, Europe, and internationally. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.